Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 May 2;100(18):e1930-e1943.
doi: 10.1212/WNL.0000000000207157. Epub 2023 Mar 16.

Association of Mitochondrial DNA Copy Number With Brain MRI Markers and Cognitive Function: A Meta-analysis of Community-Based Cohorts

Collaborators, Affiliations
Meta-Analysis

Association of Mitochondrial DNA Copy Number With Brain MRI Markers and Cognitive Function: A Meta-analysis of Community-Based Cohorts

Yuankai Zhang et al. Neurology. .

Abstract

Background and objectives: Previous studies suggest that lower mitochondrial DNA (mtDNA) copy number (CN) is associated with neurodegenerative diseases. However, whether mtDNA CN in whole blood is related to endophenotypes of Alzheimer disease (AD) and AD-related dementia (AD/ADRD) needs further investigation. We assessed the association of mtDNA CN with cognitive function and MRI measures in community-based samples of middle-aged to older adults.

Methods: We included dementia-free participants from 9 diverse community-based cohorts with whole-genome sequencing in the Trans-Omics for Precision Medicine (TOPMed) program. Circulating mtDNA CN was estimated as twice the ratio of the average coverage of mtDNA to nuclear DNA. Brain MRI markers included total brain, hippocampal, and white matter hyperintensity volumes. General cognitive function was derived from distinct cognitive domains. We performed cohort-specific association analyses of mtDNA CN with AD/ADRD endophenotypes assessed within ±5 years (i.e., cross-sectional analyses) or 5-20 years after blood draw (i.e., prospective analyses) adjusting for potential confounders. We further explored associations stratified by sex and age (<60 vs ≥60 years). Fixed-effects or sample size-weighted meta-analyses were performed to combine results. Finally, we performed mendelian randomization (MR) analyses to assess causality.

Results: We included up to 19,152 participants (mean age 59 years, 57% women). Higher mtDNA CN was cross-sectionally associated with better general cognitive function (β = 0.04; 95% CI 0.02-0.06) independent of age, sex, batch effects, race/ethnicity, time between blood draw and cognitive evaluation, cohort-specific variables, and education. Additional adjustment for blood cell counts or cardiometabolic traits led to slightly attenuated results. We observed similar significant associations with cognition in prospective analyses, although of reduced magnitude. We found no significant associations between mtDNA CN and brain MRI measures in meta-analyses. MR analyses did not reveal a causal relation between mtDNA CN in blood and cognition.

Discussion: Higher mtDNA CN in blood is associated with better current and future general cognitive function in large and diverse communities across the United States. Although MR analyses did not support a causal role, additional research is needed to assess causality. Circulating mtDNA CN could serve nevertheless as a biomarker of current and future cognitive function in the community.

PubMed Disclaimer

Conflict of interest statement

B.M. Psaty serves on the Steering Committee of the Yale Open Data Access Project, funded by Johnson & Johnson. The other authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

Figures

Figure 1
Figure 1. Study Design and Data Contribution by Cohort
The x-axis is the time interval in years between the blood draw and cognition/MRI measures. *Blood draw and cognitive function assessment were conducted at the same time in the HCHS/SOL. ARIC = Atherosclerosis Risk in Communities study; CARDIA = Coronary Artery Risk Development in Young Adults study; CHS = Cardiovascular Health Study; CN = copy number; FHS = Framingham Heart Study; GeneSTAR = Genetic Study of Atherosclerosis Risk; GENOA = Genetic Epidemiology Network of Arteriopathy Study; GOBS = Genetics of Brain Structure and Function Study; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; MESA = Multi-Ethnic Study of Atherosclerosis; mtDNA = mitochondrial DNA.
Figure 2
Figure 2. Forest Plots of the Association of mtDNA CN With General Cognitive Function per Cohort and Meta-analysis Results
Covariates included age, sex, batch effect, self-reported race/ethnicity, the time between blood draw and cognitive evaluation, cohort-specific variables, and education. β is the estimated difference in standardized general cognitive function score per SD unit increment in mtDNA CN. (A) Cross-sectional analyses. (B) Prospective analyses. ARIC = Atherosclerosis Risk in Communities study; CARDIA = Coronary Artery Risk Development in Young Adults study; CHS = Cardiovascular Health Study; CN = copy number; FHS = Framingham Heart Study; GeneSTAR = Genetic Study of Atherosclerosis Risk; GENOA = Genetic Epidemiology Network of Arteriopathy Study; GOBS = Genetics of Brain Structure and Function Study; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; MESA = Multi-Ethnic Study of Atherosclerosis; mtDNA = mitochondrial DNA.
Figure 3
Figure 3. Forest Plots of the Sex-Specific Association of mtDNA CN With General Cognitive Function per Cohort and Meta-analysis Results
Covariates included age, batch effect, self-reported race/ethnicity, the time between blood draw and cognitive evaluation, cohort-specific variables, and education. β is the estimated difference in standardized general cognitive function score per SD unit increment in mtDNA CN. (A) Cross-sectional analyses. (B) Prospective analyses. ARIC = Atherosclerosis Risk in Communities study; CARDIA = Coronary Artery Risk Development in Young Adults study; CHS = Cardiovascular Health Study; CN = copy number; FHS = Framingham Heart Study; GeneSTAR = Genetic Study of Atherosclerosis Risk; GENOA = Genetic Epidemiology Network of Arteriopathy Study; GOBS = Genetics of Brain Structure and Function Study; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; MESA = Multi-Ethnic Study of Atherosclerosis; mtDNA = mitochondrial DNA.
Figure 4
Figure 4. Forest Plots of the Age-Specific Association of mtDNA CN With General Cognitive Function per Cohort and Meta-analysis Results
Covariates included age, sex, batch effect, self-reported race/ethnicity, the time between blood draw and cognitive evaluation, cohort-specific variables, and education. β is the estimated difference in standardized general cognitive function score per SD unit increment in mtDNA CN. (A) Cross-sectional analyses. (B) Prospective analyses. ARIC = Atherosclerosis Risk in Communities study; CARDIA = Coronary Artery Risk Development in Young Adults study; CHS = Cardiovascular Health Study; CN = copy number; FHS = Framingham Heart Study; GeneSTAR = Genetic Study of Atherosclerosis Risk; GENOA = Genetic Epidemiology Network of Arteriopathy Study; GOBS = Genetics of Brain Structure and Function Study; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; MESA = Multi-Ethnic Study of Atherosclerosis; mtDNA = mitochondrial DNA.
Figure 5
Figure 5. Forest Plots of the Race/Ethnicity-Specific Association of mtDNA CN With General Cognitive Function per Cohort and Meta-analysis Results
Covariates included age, sex, batch effect, the time between blood draw and cognitive evaluation, cohort-specific variables, and education. β is the estimated difference in standardized general cognitive function score per SD unit increment in mtDNA CN. (A) Cross-sectional analyses. (B) Prospective analyses. ARIC = Atherosclerosis Risk in Communities study; CARDIA = Coronary Artery Risk Development in Young Adults study; CHS = Cardiovascular Health Study; CN = copy number; FHS = Framingham Heart Study; GeneSTAR = Genetic Study of Atherosclerosis Risk; GENOA = Genetic Epidemiology Network of Arteriopathy Study; GOBS = Genetics of Brain Structure and Function Study; HCHS/SOL = Hispanic Community Health Study/Study of Latinos; MESA = Multi-Ethnic Study of Atherosclerosis; mtDNA = mitochondrial DNA.

References

    1. Mokdad AH, Ballestros K, Echko M, et al. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444-1472. - PMC - PubMed
    1. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17:327-406. - PubMed
    1. Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207-216. - PMC - PubMed
    1. Mosconi L, Pupi A, De Leon MJ. Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease. Ann NY Acad Sci. 2008;1147(1):180-195. - PMC - PubMed
    1. Voet D. Fundamentals of Biochemistry. Wiley; 2016.

Publication types

Substances